Pharma Marketing Academy
Pharma Marketing Academy consults and partners with clients worldwide to achieve meaningful and lasting improvements in the marketing knowledge, skills and performance of their people. We leverage our practical pharma marketing and training expertise to build and deliver world-class learning solutions that make a tangible difference to the business.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
M3 (EU)
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Company Details
Latest Content from PMHub
Video: Patient level prescribing decisions
White Papers and Resources | February 9, 2016 | Inizio
Quantitative Director Duncan Munro explores the benefits of using patient level prescribing decisions.There is no “one size fits all” approach to conducting demand assessments. The best studies utilise a methodology...
Pharma Market Research Report – Predictions for 2016
White Papers and Resources | February 9, 2016 | Inizio
PMR invited US President Harriet Kozak to submit her predictions for 2016
Pharmaceutical Market Research Conference 2016
White Papers and Resources | February 9, 2016 | Inizio
Research Partnership exhibited and presented a paper at the Pharmaceutical Market Research Conference last week in Parsippany, NJ.Representing Research Partnership were US President Harriet Kozak and Director Phil Rosenberg.Harriet presented the paper...
Nicole Bender Moreira promoted to Associate Director, Singapore office
White Papers and Resources | February 9, 2016 | Inizio
Research Partnership is delighted to announce the promotion of Nicole Bender Moreira to Associate Director in recognition of the contribution she has made to the growing success of our Singapore...
New appointments announced across Research Partnership’s global offices
White Papers and Resources | February 9, 2016 | Inizio
We are delighted to welcome Marianne Jaeger as Associate Director to our London headquarters
What to Consider When Conducting Patient Research in Saudi Arabia
White Papers and Resources | February 9, 2016 | Inizio
The need to understand the patient as a key stakeholder is now recognized by pharma across the globe.
Research Partnership hires Graphic Designer to create storytelling deliverables
White Papers and Resources | February 9, 2016 | Inizio
Research Partnership has extended its healthcare research and consulting offering to include storytelling deliverables with the hire of multi-media graphic designer Amanda Brent at the company’s London headquarters. Working with...
I want to ride my bicycle, I want to ride my bike!
White Papers and Resources | February 9, 2016 | Say Communications
Our team’s motivations behind cycling on two static bikes for 282 miles - the equivalent of London to Paris, to raise money for British Dupuytren’s Society. Please donate!
A Lucid Induction
Press Releases | February 5, 2016 | Lucid Group Communications Limited
Lucid Group kick off 2016 with six new employees
What pharma needs to know about genomic data in 2016
White Papers and Resources | February 3, 2016 | Blue Latitude Health
Consultant David Cooney from Blue Latitude Health talks us through what this progress in genomics means for pharma in 2016.